Ruxolitinib (phosphate) |
A potent ATP mimetic that inhibits JAK1 and JAK2 with IC50 values of 2.7 a… |
10 mg |
23215-10 |
More Info
|
Ruxolitinib (phosphate) |
A potent ATP mimetic that inhibits JAK1 and JAK2 with IC50 values of 2.7 a… |
25 mg |
23215-25 |
More Info
|
Ruxolitinib (phosphate) |
A potent ATP mimetic that inhibits JAK1 and JAK2 with IC50 values of 2.7 a… |
5 mg |
23215-5 |
More Info
|
RVX-208 |
A selective antagonist of BET bromodomains, binding with 10-100-fold highe… |
1 mg |
16424-1 |
More Info
|
RVX-208 |
A selective antagonist of BET bromodomains, binding with 10-100-fold highe… |
10 mg |
16424-10 |
More Info
|
RVX-208 |
A selective antagonist of BET bromodomains, binding with 10-100-fold highe… |
25 mg |
16424-25 |
More Info
|
RVX-208 |
A selective antagonist of BET bromodomains, binding with 10-100-fold highe… |
5 mg |
16424-5 |
More Info
|
RVX-297 |
A BD2 bromodomain inhibitor; inhibits BD2 in BRD2, BRD3, and BRD4 (IC50s =… |
10 mg |
38777-10 |
More Info
|
RVX-297 |
A BD2 bromodomain inhibitor; inhibits BD2 in BRD2, BRD3, and BRD4 (IC50s =… |
25 mg |
38777-25 |
More Info
|
RVX-297 |
A BD2 bromodomain inhibitor; inhibits BD2 in BRD2, BRD3, and BRD4 (IC50s =… |
5 mg |
38777-5 |
More Info
|
RVX-297 |
A BD2 bromodomain inhibitor; inhibits BD2 in BRD2, BRD3, and BRD4 (IC50s =… |
50 mg |
38777-50 |
More Info
|
RWJ 67657 |
An orally active, selective inhibitor of p38α and p38β (IC50s =… |
1 mg |
18718-1 |
More Info
|
RWJ 67657 |
An orally active, selective inhibitor of p38α and p38β (IC50s =… |
10 mg |
18718-10 |
More Info
|
RWJ 67657 |
An orally active, selective inhibitor of p38α and p38β (IC50s =… |
5 mg |
18718-5 |
More Info
|
RWJ 67657 |
An orally active, selective inhibitor of p38α and p38β (IC50s =… |
50 mg |
18718-50 |
More Info
|
RWJ 52353 (hydrochloride) |
An α2D-AR agonist (Kis = 1.5, 254, 621, and 443 nM for α2D-, &… |
1 mg |
11942-1 |
More Info
|
RWJ 52353 (hydrochloride) |
An α2D-AR agonist (Kis = 1.5, 254, 621, and 443 nM for α2D-, &… |
10 mg |
11942-10 |
More Info
|
RWJ 52353 (hydrochloride) |
An α2D-AR agonist (Kis = 1.5, 254, 621, and 443 nM for α2D-, &… |
5 mg |
11942-5 |
More Info
|
RW2 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 73… |
1 mg |
37492-1 |
More Info
|
RW2 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 73… |
10 mg |
37492-10 |
More Info
|
RW2 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 73… |
25 mg |
37492-25 |
More Info
|
RW2 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 73… |
5 mg |
37492-5 |
More Info
|
RW3 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 16… |
10 mg |
37493-10 |
More Info
|
RW3 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 16… |
25 mg |
37493-25 |
More Info
|
RW3 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 16… |
5 mg |
37493-5 |
More Info
|
RW3 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 16… |
50 mg |
37493-50 |
More Info
|
RW4 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 9.… |
1 mg |
37494-1 |
More Info
|
RW4 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 9.… |
10 mg |
37494-10 |
More Info
|
RW4 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 9.… |
25 mg |
37494-25 |
More Info
|
RW4 (trifluoroacetate salt) |
An antimicrobial peptide; active against E. coli and S. aureus (IC50s = 9.… |
5 mg |
37494-5 |
More Info
|
RY785 |
A selective inhibitor of Kv2.1 voltage-gated potassium channels (IC50 = 0.… |
1 mg |
19813-1 |
More Info
|
RY785 |
A selective inhibitor of Kv2.1 voltage-gated potassium channels (IC50 = 0.… |
10 mg |
19813-10 |
More Info
|
RY785 |
A selective inhibitor of Kv2.1 voltage-gated potassium channels (IC50 = 0.… |
5 mg |
19813-5 |
More Info
|
RY785 |
A selective inhibitor of Kv2.1 voltage-gated potassium channels (IC50 = 0.… |
500 µg |
19813-500 |
More Info
|
RYTVELA (trifluoroacetate salt) |
A deriviative of rytvela,, |
1 mg |
37490-1 |
More Info
|
RYTVELA (trifluoroacetate salt) |
A deriviative of rytvela,, |
10 mg |
37490-10 |
More Info
|
RYTVELA (trifluoroacetate salt) |
A deriviative of rytvela,, |
5 mg |
37490-5 |
More Info
|
Ryuvidine |
An inhibitor of SETD8 (IC50 = 0.5 µM) that suppresses monomethylatio… |
1 mg |
16614-1 |
More Info
|
Ryuvidine |
An inhibitor of SETD8 (IC50 = 0.5 µM) that suppresses monomethylatio… |
10 mg |
16614-10 |
More Info
|
Ryuvidine |
An inhibitor of SETD8 (IC50 = 0.5 µM) that suppresses monomethylatio… |
25 mg |
16614-25 |
More Info
|
Ryuvidine |
An inhibitor of SETD8 (IC50 = 0.5 µM) that suppresses monomethylatio… |
5 mg |
16614-5 |
More Info
|
S 14506 |
A 5-HT1A receptor agonist; selectively binds 5-HT1A over 5-HT1B, 5-HT1C, 5… |
1 mg |
32838-1 |
More Info
|
S 14506 |
A 5-HT1A receptor agonist; selectively binds 5-HT1A over 5-HT1B, 5-HT1C, 5… |
10 mg |
32838-10 |
More Info
|
S 14506 |
A 5-HT1A receptor agonist; selectively binds 5-HT1A over 5-HT1B, 5-HT1C, 5… |
5 mg |
32838-5 |
More Info
|
S 2101 |
An LSD1 inhibitor (Ki = 0.61 µM); selective for LSD1 over MAO-A and… |
1 mg |
19802-1 |
More Info
|
S 2101 |
An LSD1 inhibitor (Ki = 0.61 µM); selective for LSD1 over MAO-A and… |
10 mg |
19802-10 |
More Info
|
S 2101 |
An LSD1 inhibitor (Ki = 0.61 µM); selective for LSD1 over MAO-A and… |
25 mg |
19802-25 |
More Info
|
S 2101 |
An LSD1 inhibitor (Ki = 0.61 µM); selective for LSD1 over MAO-A and… |
5 mg |
19802-5 |
More Info
|
S0859 |
An N-cyanosulphonamide that selectively blocks the sodium / bicarbonate co… |
1 mg |
18497-1 |
More Info
|
S0859 |
An N-cyanosulphonamide that selectively blocks the sodium / bicarbonate co… |
10 mg |
18497-10 |
More Info
|